PRAXIS PRECISION MEDICINES I

$4.66 0.00% ($0.00)

Get ready to invest

About PRAXIS PRECISION MEDICINES I

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating genetic insights into the development of therapies for central nervous system (CNS) disorders. Its portfolio of CNS programs is structured by therapeutic focus in three primary franchises, which include Psychiatry, Movement Disorders, and Epilepsy. It has three product candidates, which include PRAX-114, PRAX-944 and PRAX-562. PRAX-114 is an extra synaptic gamma-aminobutyric acid-A (GABAA) receptor preferring positive allosteric modulator (PAM) for the treatment of a range of patients suffering from major depressive disorder (MDD) and perimenopausal depression (PMD). PRAX-944 is a differentiated selective small molecule inhibitor of T-type calcium channels developed for the treatment of Essential Tremor (ET) and Parkinson's Disease(PD). PRAX-114 is developed for the treatment of a range of patients suffering from post-traumatic stress disorder (PTSD).

Popular Stocks	Price	Change
Bed Bath & Beyond BBBY	$20.63 28.94%	28.94%
AMTD International ADR AMTD	$2.82 24.78%	24.78%
Nu Holdings NU	$5.51 17.74%	17.74%
AMC AMC	$24.8864 2.79%	2.79%
AMD AMD	$100.29 0.71%	0.71%
SoFi SOFI	$7.585 0.46%	0.46%
Ginkgo Bioworks Holdings DNA	$3.75 7.45%	7.45%
Snap SNAP	$12.585 2.82%	2.82%
Carnival CCL	$11.195 4.53%	4.53%
fuboTV FUBO	$6.4899 48.17%	48.17%